SCHEMBL23901099

SCHEMBL23901099

COc1cc(N2CCN(C)CC2)ccc1Nc1ccccn1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 6/20 0.55
INSR P06213 3/20 0.55
NPM1 P06748 2/20 0.55
EGFR P00533 4/20 0.55
ULK1 O75385 1/20 0.55
IGF1R P08069 2/20 0.52
CDK2 P24941 1/20 0.52
DYRK1B Q9Y463 1/20 0.52
TNK2 Q07912 4/20 0.52
DCLK1 O15075 2/20 0.52
MAPK7 Q13164 2/20 0.52
LRRK2 Q5S007 2/20 0.52
GAK O14976 1/20 0.52
BRD4 O60885 1/20 0.52
TNK1 Q13470 1/20 0.52
DCLK2 Q8N568 1/20 0.52
DYRK1A Q13627 1/20 0.51
JAK2 O60674 1/20 0.51
SRC P12931 1/20 0.51
FGFR2 P21802 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30020501 0.90 INSR (0.62) ALKINSRNPM1EGFRIGF1R
SCHEMBL30340921 0.85 IGF1R (0.54) ALKINSREGFRIGF1RCDK2
SCHEMBL30340630 0.82 MAPK10 (0.51) ALKINSRNPM1EGFRIGF1R
SCHEMBL28999541 0.81 CTSC (0.55) ALKINSRNPM1EGFRTNK2
SCHEMBL30340587 0.81 CDK2 (0.55) ALKINSRNPM1EGFRIGF1R
SCHEMBL30039901 0.81 EGFR (0.70) ALKINSREGFRIGF1RCDK2
SCHEMBL12887598 0.81 ULK1 (0.51) ALKINSRNPM1ULK1IGF1R
SCHEMBL28053990 0.81 ALK (0.59) ALKINSREGFRIGF1RCDK2
SCHEMBL30340484 0.80 CDK2 (0.56) ALKEGFRIGF1RCDK2DYRK1B
SCHEMBL30340614 0.80 ADRA2A (0.63) EGFRIGF1RCDK2DYRK1BGAK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021197467-A1 MULTI-TARGET ANTI-TUMOR COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 上海华汇拓医药科技有限公司 2021-10-07 WO disclosed